Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men

Status unconfirmed · Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat. The amount of heterocyclic amines in the diet may affect prostate cancer screening results and the risk of prostate cancer. PURPOSE: This phase II trial is studying prostate cancer screening and dietary heterocyclic amines in African American men.

Key facts

Study ID

NCT00354497

Run by

Lawrence Livermore National Laboratory at University of California

People needed

800

Starts

2002-03-01

Last updated by the study team

2013-09-20

Who can join

Age: 50 and older, up to 70. Sex: male. Healthy volunteers: accepted.

Where it is running

• Lawrence Livermore National Laboratory at University of California — Livermore, California, United States (enrolling)
• Alta Bates Summit Medical Center - Summit Campus — Oakland, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.